---
title: Reduce freezing of gait remotely
nct_id: NCT06957405
phase: NA
status: RECRUITING
sponsor: University of Sao Paulo General Hospital
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06957405"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06957405"
last_fetched: "2026-05-10T14:03:09.216Z"
source: "Parkinson's Pathways (curated)"
---
# Reduce freezing of gait remotely

**Goal (in five words):** Reduce freezing of gait remotely

**Official Title:** Effects of a Remote Mental and Physical Practice Intervention on Freezing of Gait in People With Parkinson's Disease: a Randomized Controlled Trial

**Trial ID:** [NCT06957405](https://clinicaltrials.gov/study/NCT06957405)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** University of Sao Paulo General Hospital
- **Target Enrollment:** 50 participants
- **Start Date:** 2025-01-25
- **Completion Date:** 2025-08
- **Conditions:** Parkinson Disease, Freezing of Gait
- **Interventions:** MPPG (Mental and Physical Practice Group), PPG (Physical Practice Group)
- **Intervention Types:** BEHAVIORAL

## Summary For Families

The goal is to reduce freezing of gait, those sudden moments when your feet feel glued to the floor, so walking becomes more fluid and less frightening. The intervention uses remote sessions that combine motor imagery, where you vividly rehearse walking and turning in your mind, with guided physical practice over video calls; the mental rehearsal is meant to strengthen the brain circuits that plan and trigger steps. These are non-drug therapies used alongside your usual dopaminergic medications, they do not replace levodopa but may help improve gait control when you are on medication. The trial is looking for about 50 people with idiopathic Parkinson's who report freezing of gait, can walk independently at home, use dopaminergic meds, have internet and a video device, and meet brief cognitive and motor imagery screening.

## Eligibility

- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Clinical diagnosis of idiopathic PD;
* Use of dopaminergic medication;
* Experiencing FOG (positive response to the first question of the New Freezing of Gait Questionnaire - NFOG-Q);
* Able to walk independently at home;
* Access to internet and video call device;
* Agree to participate in the study.

Exclusion Criteria:

* Other neurological disorders;
* Severe cardiovascular and/or respiratory alterations;
* Uncorrected visual and/or auditory alterations;
* Cognitive impairment, detectable through the Telephone Montreal Cognitive Assessment (T-MoCA, \< 12);
* Inability to perform motor imageryT during the administration of the Kinesthetic and Visual Imagery Questionnaire - 20 (KVIQ-20, \< 20)
```

## Locations (1)

- University of Sao Paulo, São Paulo, São Paulo, Brazil _(-23.5475, -46.6361)_
  - Maria Elisa P Piemonte, PT, PHD — (CONTACT) — 55 11 30917451 — elisapp@usp.br
  - Paloma R Silva, PT — (CONTACT) — 55 11 976193193 — paloma.rsilva@usp.br
  - Maria Elisa P Piemonte, PT, PHD — (PRINCIPAL_INVESTIGATOR)
  - Paloma R Silva, PT — (PRINCIPAL_INVESTIGATOR)

## Central Contacts

- Maria Elisa P Piemonte, PT, PHD — (CONTACT) — 55 11 30917451 — elisapp@usp.br
- Paloma R Silva, PT — (CONTACT) — 55 11 976193193 — paloma.rsilva@usp.br

---

*Canonical: https://parkinsonspathways.com/trial/NCT06957405*  
*HTML version: https://parkinsonspathways.com/trial/NCT06957405*  
*Source data: https://clinicaltrials.gov/study/NCT06957405*